|
|
|
|
|||||
|
|
|
Information Regarding the Total Number of Voting Rights and
Total Number of Shares of the Company as of February 28, 2026
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 02/28/2026 | 278,352,082 | Total gross of voting rights: 278,352,082 |
| Total net* of voting rights: 278,236,200 |
* Net total = total number of voting rights attached to shares – shares without voting rights
Attachment
| Mar-03 | |
| Feb-28 | |
| Feb-13 | |
| Feb-10 | |
| Feb-09 | |
| Feb-05 | |
| Jan-16 | |
| Jan-12 | |
| Jan-07 | |
| Jan-05 | |
| Dec-21 | |
| Dec-17 |
DBV Launches, Up As Much As 46%, On A New Approach To Peanut Allergy
DBVT +25.42%
Investor's Business Daily
|
| Dec-17 | |
| Dec-17 |
DBV to make new approval bid for VIASKIN Peanut on Phase III trial
DBVT +25.42%
Clinical Trials Arena
|
| Dec-16 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite